Moreover, following cisplatin-based treatment, the control tumors with higher induced GDF15 had a higher stromal component, whereas the GDF15-KD tumors did not have a significant change in the tumor-stroma ratio, suggesting that GDF15 secreted by tumor cells can protect or recruit stromal cells against this treatment. Here, GDF15 is linked to neoplasm.